Cannabinoid receptors are localized to noradrenergic axon terminals in the rat frontal cortex
- 17 November 2006
- journal article
- Published by Elsevier BV in Brain Research
- Vol. 1127 (1), 36-44
- https://doi.org/10.1016/j.brainres.2006.09.110
Abstract
No abstract availableThis publication has 58 references indexed in Scilit:
- Upregulation of CB1 receptors and agonist-stimulated [35S]GTPγS binding in the prefrontal cortex of depressed suicide victimsMolecular Psychiatry, 2004
- The CB1 receptor antagonist SR141716A selectively increases monoaminergic neurotransmission in the medial prefrontal cortex: implications for therapeutic actionsBritish Journal of Pharmacology, 2003
- Alcohol, cannabis and tobacco use among Australians: a comparison of their associations with other drug use and use disorders, affective and anxiety disorders, and psychosisAddiction, 2001
- Cannabinoid receptor agonist WIN 55,212‐2 inhibits rat cortical dialysate γ‐aminobutyric acid levelsJournal of Neuroscience Research, 2001
- Reduction of opioid dependence by the CB1 antagonist SR141716A in mice: evaluation of the interest in pharmacotherapy of opioid addictionBritish Journal of Pharmacology, 2001
- Modulation by fluoxetine of striatal dopamine release following Δ9‐tetrahydrocannabinol: a microdialysis study in conscious ratsBritish Journal of Pharmacology, 1999
- Cannabinoid and Heroin Activation of Mesolimbic Dopamine Transmission by a Common µ 1 Opioid Receptor MechanismScience, 1997
- Neuropsychological and neuroimaging evidence for the involvement of the frontal lobes in depressionJournal of Psychopharmacology, 1997
- Arousal-enhancing properties of the CB1 cannabinoid receptor antagonist SR 141716A in rats as assessed by electroencephalographic spectral and sleep-waking cycle analysisLife Sciences, 1996
- Cortical noradrenaline, attention and arousalPsychological Medicine, 1984